Form S-3 - Registration statement under Securities Act of 1933:
SEC Accession No. 0001683168-25-000107
Filing Date
2025-01-06
Accepted
2025-01-06 11:44:30
Documents
73

Document Format Files

Seq Description Document Type Size
1 REGISTRATION STATEMENT sunshine_s3.htm   iXBRL S-3 773113
2 OPINION OF BY ANDREW I. TELSEY, P.C. sunshine-ex0501.htm EX-5.1 30746
3 CONSENT OF BUSH & ASSOCIATES CPA LLC sunshine_ex2301.htm EX-23.1 2956
4 CALCULATION OF FILING FEE TABLES sunshine-ex107.htm EX-FILING FEES 51982
5 GRAPHIC image_001.jpg GRAPHIC 7392
11 GRAPHIC image_007.jpg GRAPHIC 7320
  Complete submission text file 0001683168-25-000107.txt   4929205

Data Files

Seq Description Document Type Size
6 XBRL SCHEMA FILE sbfm-20231231.xsd EX-101.SCH 40711
7 XBRL CALCULATION FILE sbfm-20231231_cal.xml EX-101.CAL 54393
8 XBRL DEFINITION FILE sbfm-20231231_def.xml EX-101.DEF 143421
9 XBRL LABEL FILE sbfm-20231231_lab.xml EX-101.LAB 356472
10 XBRL PRESENTATION FILE sbfm-20231231_pre.xml EX-101.PRE 302547
75 EXTRACTED XBRL INSTANCE DOCUMENT sunshine_s3_htm.xml XML 555132
Mailing Address 333 LAS OLAS WAY CU4 SUITE 433 FORT LAUDERDALE FL 33301
Business Address 333 LAS OLAS WAY CU4 SUITE 433 FORT LAUDERDALE FL 33301 954-515-0810
Sunshine Biopharma Inc. (Filer) CIK: 0001402328 (see all company filings)

EIN.: 205566275 | State of Incorp.: CO | Fiscal Year End: 1231
Type: S-3 | Act: 33 | File No.: 333-284142 | Film No.: 25509618
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)